首页> 外文期刊>Journal of neurointerventional surgery >Zygomatico-orbital intra-arterial melphalan infusion for intraocular retinoblastoma
【24h】

Zygomatico-orbital intra-arterial melphalan infusion for intraocular retinoblastoma

机译:y眶眶动脉美法仑输注治疗眼内视网膜母细胞瘤

获取原文
获取原文并翻译 | 示例
           

摘要

Retinoblastoma is a rare and curable malignancy affecting the pediatric population. For advanced stage intraocular retinoblastoma, enucleation remains the primary treatment modality, although the use of laser photocoagulation, cryotherapy, radiotherapy and chemotherapy are frequently used, particularly in the setting of bilateral disease. Intravenous chemotherapy is the long-standing method of delivery, but local administration (subtenon, intravitreal or intra-arterial) is gaining in popularity because of the reduced side effects related to systemic administration. Of these newer methods, intra-arterial infusion has demonstrated technical feasibility, few procedural complications and robust tumor response. A case is described where a collateral supply to the affected ophthalmic artery was via the zygomatico-orbital branch of the ipsilateral superficial temporal artery. Melphalan infusion was performed via this pathway without incident.
机译:视网膜母细胞瘤是一种罕见且可治愈的恶性肿瘤,会影响儿科人群。对于晚期眼内视网膜母细胞瘤,摘除术仍然是主要的治疗方式,尽管经常使用激光光凝,冷冻疗法,放射疗法和化学疗法,特别是在双侧疾病的情况下。静脉化疗是一种长期的分娩方法,但是由于减少了与全身给药有关的副作用,局部给药(亚腱,玻璃体内或动脉内给药)正逐渐普及。在这些较新的方法中,动脉内输注已显示出技术可行性,极少的程序并发症和强大的肿瘤反应。描述了一种情况,其中通过患侧浅颞动脉的zy眶眶分支向受影响的眼科动脉提供侧支。美法仑输注是通过该途径进行的,没有发生任何事故。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号